Luspatercept
ATC B03XA06 · 9 markets · 18 records
Luspatercept
Forms
US 2 records · 2 strengths
CA 2 records · 2 strengths
AU 2 records · 2 strengths
- 75 mginjectionREBLOZYL luspatercept 25 mg powder for injection vial
- 25 mginjectionREBLOZYL luspatercept 25 mg powder for injection vial
SG 2 records · 2 strengths
- 75 mg/vialinjectionREBLOZYL POWDER FOR SOLUTION FOR INJECTION 25 MG/VIAL
- 25 mg/vialinjectionREBLOZYL POWDER FOR SOLUTION FOR INJECTION 25 MG/VIAL
ES 2 records · 2 strengths
TW 2 records · 1 strengths
Records without a stated strength · 1 Reblozyl powder for solution for injection、芮寶喜凍晶注射劑、芮寶興凍晶注射劑
HK 2 records · 1 strengths
Records without a stated strength · 1 Reblozyl powder for solution for injection
MX 1 records · 1 strengths
Records without a stated strength · 1 Reblozyl
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Reblozyl
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.